Peptinov was founded in 2010 and is located in the campus of Cochin Hospital in Paris. Peptinov is a privately held biotechnology company focused on the development of peptide-based immunotherapies targeting self-proteins, for the treatment of chronic inflammatory diseases and cancers.
